Three of five studies eligible for assessing Ki-67 in ESCC demonstrated a pooled HR of 1.11 (95% CI, 0.70-1.78) with no significant of heterogeneity. This evidence concerns the gene MKI67 and esophageal squamous cell carcinoma.